Also available in Persian — نسخه فارسی ✈️ Telegram EN فا
❓ Unknown

Health Commission of Parliament: 'Drug Crisis' Continues; Ghalibaf: Drugs are 'Stockpiled' in Customs

Feb 7, 2026 February 7, 2026 3 min read 📰 VOA Persian
📋 Key Takeaway

The Iranian Parliament's Health Commission reports a continuing drug crisis, with Speaker Ghalibaf stating that drugs are stockpiled in customs and not reaching the public. Despite government promises, shortages persist, affecting vulnerable patients. This situation highlights systemic issues in Iran's pharmaceutical industry amid ongoing sanctions.

🔍 Quick Context Guide
💡 Bottom Line: Iran's drug crisis reveals systemic issues in healthcare management, affecting vulnerable populations and highlighting economic challenges.

👥 Key Players

Mohammad Baqer Ghalibaf MENTIONED
Speaker of the Islamic Consultative Assembly
"As the Speaker, Ghalibaf is a key figure in Iran's legislative body and influences policy discussions and decisions."
Salman Ishaqi MENTIONED
Member of the Islamic Consultative Assembly
"Ishaqi is involved in the Health Commission, which oversees health policy and addresses the drug crisis."
Ali Babaei Karami MENTIONED
Member of the Social Commission of the parliament
"Karami highlights the impact of the drug crisis on vulnerable patient groups, emphasizing the social implications."
Morteza Khairabadi MENTIONED
Member of the Human Pharmaceutical Industry Syndicate
"Khairabadi provides insight into the pharmaceutical industry's challenges, including factory relocations."

📰 What Happened

Iran faces a drug crisis with significant shortages and stockpiling issues, as drugs are reportedly held in customs and not reaching patients. Parliamentary discussions highlight systemic failures in drug supply and management.

  • Drugs are reportedly stockpiled in customs and not distributed to the public.
  • There is a severe shortage of over 200 drug items affecting vulnerable patients.

💡 Why It Matters

🇮🇷 For Iran: The drug crisis affects public health and highlights inefficiencies in government management, impacting public trust.
🌍 Regional: Regional stability could be affected if Iran's healthcare system continues to struggle, potentially influencing neighboring countries.
🌐 International: While sanctions do not directly target medical supplies, the crisis underscores broader economic and political challenges in Iran.

📚 Background

Iran's healthcare system is under strain due to economic sanctions, mismanagement, and internal policy challenges, despite medical supplies being exempt from sanctions.

Iranian healthcare system Economic sanctions on Iran
📡 Source: STATE MEDIA
📊 Confidence: 70%
The source reflects the perspective of Iranian state media, which may downplay government responsibility or externalize blame.

Following the escalation of the drug and medical crisis in Iran, as well as protests from patients and various sectors of the Iranian health system, the Speaker of the Islamic Consultative Assembly has reported the existence of drugs, stating that a large quantity is 'stockpiled' in customs. According to Iranian media, Mohammad Baqer Ghalibaf, the Speaker of the Islamic Consultative Assembly, stated in today's public session on Tuesday, June 29, that drugs are 'stockpiled' in customs and medical supplies 'do not reach the people.' After presenting the third report from the Health and Treatment Commission regarding 'the performance of executive bodies in the areas of importing and clearing medical equipment and managing the drug market' to the parliament and announcing a severe shortage of certain drug items in the country, he said: 'We should not witness such strokes in the field of drugs and medical equipment.' The Speaker of the Islamic Consultative Assembly noted that the 'value-added tax' on essential goods, drugs, and medical equipment has been set at 'one percent', declaring that this rate for drugs should be 'zero'. Drugs and medical services have faced severe price increases along with shortages in recent years, while drugs and medical affairs are not subject to the punitive sanctions of the United States and the international community, and the Islamic Republic can take necessary actions to procure them. Meanwhile, Salman Ishaqi, a member of the Islamic Consultative Assembly, in explaining the third report from the Health Commission on the performance of executive bodies in managing medical and drug equipment, called for a 'proactive approach' by the Ministry of Health and Treatment of Ebrahim Raisi's government. He stated that despite numerous promises from government officials, the 'drug crisis continues', adding that now it is time for the 'shortage and rampant price increase' of medical equipment. On the other hand, Ali Babaei Karami, a member of the Social Commission of the parliament, also stated today that transplant patients, hemophiliacs, and special patients are 'facing problems in obtaining drugs.' He noted that 'more than 200 items' of drugs are facing 'shortages' in the country, stating that they have blocked the import of foreign drugs to 'produce drugs domestically', but domestic companies are 'not supported.' The import of drugs and the pharmaceutical industry in Iran is facing numerous challenges, to the extent that on June 10, a member of the 'Pharmaceutical Industry Owners Syndicate' reported the transfer of several pharmaceutical factories to Turkey. Morteza Khairabadi, a member of the board of directors of the Human Pharmaceutical Industry Syndicate, said a few weeks ago in a session of the Research Center of the Islamic Consultative Assembly that Turkey is trying to 'transfer our pharmaceutical factories to its own country' and has already 'completely transferred several of our pharmaceutical factories to its country.' The problem of drug and medical equipment shortages in Iran coincides with the announcement of the discovery of illegal warehouses. The CEO of the Iranian Organization of State-Owned Properties attributed the destruction of European serums during the peak of the shortage to 'lack of coordination.' A police official reported that 40 million 'rare drugs' were discovered. A member of the 'Pharmaceutical Industry Owners Syndicate' reported the transfer of several Iranian pharmaceutical factories to Turkey. The discovery of 20 million 'illegal drugs' in Tehran. One cannot get sick; there are no drugs or they are expensive.

🌐

Translated from the original and edited for English readers. View original source →

Translation confidence: 85%

📰 Related Coverage

⚖️ Independent Platform — Artesh.com is not affiliated with any government, military, or political organization. Editorial Policy →